SS-31
10 mg98.5% purityLot #SS31-2026-001
SKU della dimensione selezionata: PEP-SS31-10MG
SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a mitochondria-directed tetrapeptide composed of D-Arg-Dmt-Lys-Phe-NH2. Its unique mechanism involves selective binding to cardiolipin, an essential phospholipid located exclusively within the inner mitochondrial membrane. Through stabilization of cardiolipin and its interaction with electron transport chain complexes, SS-31 enhances electron transport efficiency, supports ATP generation, and helps minimize excessive production of reactive oxygen species (ROS). Clinical and preclinical research programs, including PROGRESS-HF, TAZPOWER, MMPOWER-3, and ReCLAIM, have demonstrated beneficial effects across multiple organ systems, including the heart, brain, kidneys, and skeletal muscle. Today, SS-31 is considered one of the most sophisticated mitochondrial-targeted therapeutic candidates in advanced clinical development.
€164.70incl. VAT
✅ Disponibile (40)
Prezzi per volume
| Quantità | Prezzo unitario | Risparmio |
|---|---|---|
| 1 vial | 164.70 € | — |
| 3 vials (−7%) | 153.72 € | −7% |
| 5 vials (−12%) | 145.18 € | −12% |
Ocene in mnenja
Prijavite se in ocenite izdelek po prejetem naročilu. accedi
Certificato di analisi
Verificato in lab✓Visualizza COA prima dell'acquisto — trasparenza garantita
Profilo di ricerca
SS-31 — profilo scientifico
Il contenuto è destinato a scopi educativi e di ricerca. Research Use Only.
- SS-31 (also known as Elamipretide, MTP-131, or Bendavia) is a mitochondria-directed tetrapeptide composed of D-Arg-Dmt-Lys-Phe-NH2. Its unique mechanism involves selective binding to cardiolipin, an essential phospholipid located exclusively within the inner mitochondrial membrane. Through stabilization of cardiolipin and its interaction with electron transport chain complexes, SS-31 enhances electron transport efficiency, supports ATP generation, and helps minimize excessive production of reactive oxygen species (ROS). Clinical and preclinical research programs, including PROGRESS-HF, TAZPOWER, MMPOWER-3, and ReCLAIM, have demonstrated beneficial effects across multiple organ systems, including the heart, brain, kidneys, and skeletal muscle. Today, SS-31 is considered one of the most sophisticated mitochondrial-targeted therapeutic candidates in advanced clinical development.
